| Literature DB >> 35497931 |
Acharya Balkrishna1,2,3, Mayur Chauhan2, Anurag Dabas2, Vedpriya Arya2,3.
Abstract
Background: Albizialebbeck is a deciduous tree having tremendous medicinal utilities, for example, respiratory, skin, gastrointestinal, oral disorders, eye, urinary, genital, anorectal, inflammatory, and neurological disorders, and venereal diseases. Several studies have been undertaken on the medicinal and traditional values of A. lebbeck. Objective: The detailed information about its medicinal uses and pharmacological implications is highly scattered and distributed in different data sources. Hence, the study was conducted to supply an inclusive review of its ethnomedicinal uses, phytochemicals, and the available pharmacological attributes supporting its efficiency in traditional medicine. Method: Literature surveys were conducted on this medicinal plant via search engines like Google Scholar, PubMed, and Science Direct, and obtained information up to December 2020 has been assessed and analyzed for this study.Entities:
Year: 2022 PMID: 35497931 PMCID: PMC9050289 DOI: 10.1155/2022/5359669
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.650
Figure 1Global distribution of medicinal species Albizia lebbeck (L.) Benth. (created with mapchart.net).
Figure 2Leaves, flowers, and pods of Albizia lebbeck (source: Patanjali Herbal Museum).
Ethnomedicinal uses of different parts of A. lebbeck in various traditional medicinal systems.
| Parts used | Medicinal system | Mode of administration | Ethnomedicinal uses | References |
|---|---|---|---|---|
| Bark | Indian traditional medicine | Asthma, bronchitis, arthritis, gingivitis, toothache, allergies, leukoderma, leprosy, snakebites, malaria, and fractures | [ | |
| Leaves | Night blindness and syphilis | [ | ||
| All parts | Snakebite, scorpion sting, hemorrhage, and gum inflammation | [ | ||
| Bark and flowers | Siddha system | Arthritis | [ | |
| Flowers | Traditional Chinese medicine | Anxiety, depression, and insomnia | [ | |
| Ayurveda | Nasya, pittaja, prameha, asthma, arthritis, burns, diarrhea, edema, poisoning, bronchitis, consumption, night blindness, respiratory disorders, skin disorders, snakebite, and scorpion sting | [ | ||
| Root | Wounds | [ | ||
| Bark | Bronchitis, leprosy, paralysis, gum inflammation, and helminthic infection | [ | ||
| Leaves | Poultice | Night blindness and ulcer | [ | |
| Flower | Juice | Poisoning, hikka (hiccup), shwasa (asthma), and eye disease | [ | |
| Seed | Piles and diarrhea | [ |
Figure 3Percentage of reported ethnomedicinal uses of A. lebbeck against myriad diseases.
Figure 4Parts usage (%) of A. lebbeck reported for various ethnomedicinal uses.
Medicinal uses of A. lebbeck in different countries of the world.
| S. no. | Country | Parts used | Mode of administration | Medicinal uses | References |
|---|---|---|---|---|---|
| 1 | Africa | Leaves, stem bark, pods, and seeds | — | Dysentery, diarrhea, bronchial asthma, eczema, insect bite, allergy, piles, hernia, malaria, gonorrhea, scrofulous swellings, earache, antiprotozoal, and anthelmintic | [ |
| Zulu of Southern Africa | Bark and roots | — | Scabies, inflamed eyes, piles, and bronchitis | [ | |
| West Africa | — | Diarrhea, dysentery, hemorrhoids, bronchitis, asthma, eczema, and leprosy | [ | ||
| 2 | Asia | Stem | — | Abdominal tumors, boils, cough, eye disorders, and lung ailments | [ |
| Bark | |||||
| 3 | Australia | Seed, = stem bark, and root bark | — | Diarrhea, gastroenteritis, hemorrhoids, bronchitis, leprosy, paralysis, parasitic infestation, ulcer, snakebite, gum ailments, abdominal tumors, boils, cough, eye disorders, and lung ailments | [ |
| 4 | Bangladesh | Bark, seed, and leaves | Decoction | Piles, diarrhea, toothache, gum ailments, bronchial asthma, allergic disorder, and ophthalmia | [ |
| 5 | China | Flowers | Anxiety, depression, and insomnia | [ | |
| 6 | India | Bark and seed | Powder and juice | Astringent, tonic, restorative, and anus pain | [ |
| Bark, flowers, seeds, and roots | Arthritis, bone fracture, edema, poisoning, asthma, bronchitis, skin disease, cold and cough, itching, pruritus, wounds healing, leprosy, malaria, gonorrhea, abscesses, boils and abdominal tumors, snakebite, scorpion sting, hemorrhage, and gum inflammation | [ | |||
| Spermatorrhea | [ | ||||
| India (Bhils and Meena tribes) | Stem bark, flowers, and leaves | Powder, paste, and decoction | Stone, boil, pimples, ulcer, gums ailments, pharyngitis, insect bite, and scorpion sting | [ | |
| India (tribes of Himachal Pradesh and Kashmir) | Inflammation | [ | |||
| India (Tamil Nadu) | Bone fractures | ||||
| 7 | Myanmar (Burma) | Abdominal tumors | [ | ||
| 8 | Nepal | Root, leaves, flowers, bark, and seed | Bark aqueous extract (leaf), decoction (seed), ointment, and powder | Snakebite, scorpion sting, hemicrania, strengthen gum, ophthalmia, cough, bronchitis, asthma, prevent conception in women, anus pain, night blindness, astringent, piles, diarrhea, dysentery, gums ailment (spongy and ulcerated gums), emollient for boils, eruption, carbuncle, swelling, eye disease, and scrofulous enlargement of glands | [ |
| 9 | Nigeria | Aqueous extract | Fever, pain, epilepsy, and inflammation | [ | |
| 10 | Philippines | Bark and leaves | Decoction | Dysentery, diarrhea, and ulcer | [ |
| 11 | Taiwan | Bark | Anthelmintic, diuretic, stimulant, tonic, and vermifuge | [ | |
| 12 | Tibet | Kapha, pitta, poisoning, erysipelas, and ulcer | [ |
Chemicals constituents of A. lebbeck.
| Chemical compounds | Plant part | References |
|---|---|---|
| Alkaloids (budmunchiamines L1–L6), | Plant | [ |
| Oleanane-type saponins (lebbeckosides A and B) | Roots | [ |
| Alkaloids, flavonoid (geraldone, luteolin, isookanin, epicatechin, and procyanidins B-2, B-5, and C-3), glycoside (albizinin), hemolysin (lebbeckalysin), oleanane triterpene (albiziasaponins A–E), phenols, phytosterols, saponins, and triterpenoid saponin (lebbeckoside C, 21-[[(2e,6S)-6-[6-deoxy-4-O-[(2e,6S)-6-hydroxy-2-(hydroxymethyl)-6-methyl-1-oxo-2,7-octadienyl]-[( | Bark | [ |
| Alkaloids, glycosides, saponin (albiziahexoside) steroids, tannins, terpenoids, flavonoids (kaempferol 3-O-a rhamnopyranosyl(1/6)-b-glucopyranosyl(1/6)-o-galactopyranoside, quercetin 3-O-a rhamnopyranosyl(1/6)-b-glucopyranosyl(1/6)-b-galactopyranoside, kaempferol, and 3-rhamnosyl (1–6) glycosyl (1–6) galactoside) | Leaves | [ |
| Alkaloids, anthraquinones, eicosane, fatty acid (linolenic acid, oleic acid, palmitic acid, and steric acid), flavonoids, glycosides, nonadecane, octadecane, phenolics, phytol, saponins (glycosaponins), steroids, stigmastadiene, tetradecane, and vitamin E | Seed | [ |
| 3′,5-Dihydroxy-4′,7 dimethoxy flavone and N-benzoyl-L-phenyl alaninol | Pod | [ |
| Albigenic acid | Bean |
Figure 5Molecular structure of various phytochemicals extracted from different parts of Albizia lebbeck.
Figure 6Different parts of Albizia lebbeck used for several pharmacological investigations.
Figure 7Mechanistic representation of different phytochemicals extracted from A. lebbeck.
Pharmacological activities of various parts of A. lebbeck.
| S. no. | Pharmacological activity | Extract, fraction, and isolate | Parts used | Dose/mode of administration | Standard | Study model/parameter | Result | Ref. |
|---|---|---|---|---|---|---|---|---|
| 1 | Antiallergic activity | Ethanolic extract | Stem bark | 50 to 300 mg/kg, p.o. | DSCG (50 mg/kg, i.p.) | Mast cell stabilization, compound 48/80-induced systemic anaphylaxis | Dose-dependent mast cell stabilization activity at 200 and 300 mg/kg dose extract protected the degranulation (53 and 61%, resp.). There was significant protection from degranulation (compound 48/80 induced) of mast cells, dose-dependent, that is, 61 and 74% of inhibition of histamine release at 200 and 300 mg/kg, respectively | [ |
| Chloroform, methanol, and water extracts | Leaf and stem bark | 50 | 1% DMSO |
| All the extracts showed significant mast cell stabilization activity. However, methanolic and water extracts of the bark showed the maximum activity along with the leaf methanolic extract | [ | ||
|
| ||||||||
| 2 | Anti-Alzheimer's activity | Hydromethanolic extract | Seed | 100–300 mg/kg p.o. | Galantamine 0.5 mg/kg |
| Extracts significantly improved the memory and cognitive impairments, ↑GSH, SOD, CAT, and ↓ AChE | [ |
| Morris water maze, open field, hole board, Y-maze, and T-maze test | ||||||||
| 3 | Anticancer activity | Saponin-rich fraction | Bark | 0.001, 0.01, 0.1, 1, and 10 | Doxorubicin 500 nM |
| Fraction inhibits the growth of MCF-7 with IC50 1 | [ |
| 10 | Staurosporine 1 ug/ml | Apoptosis assay | Fraction increases apoptosis and promotes activation of caspases 3 and 8 | |||||
| 0.1, 0.5, and 1 | Shell-less chick embryo culture assay | Reduction in number of extremities, nodes, junctions, and total branches length between 0 and 3 hr and 0 and6 hr of drug exposure | ||||||
| Chromosomal aberration (CA) assay | ↑ Total chromosomal aberrations | |||||||
| Zinc oxide nanoparticles | Stem bark | 5, 25, 50, and 100 |
| Extract significantly inhibited the viability | [ | |||
| Lebbeckosides A-B | Root | Tamoxifen |
| Lebbeckoside A and B showed cytotoxicity against TG1 and U-87 MG, with IC50 2.10, 2.24, 3.46, and 1.36 | [ | |||
| Crude methanol extract | Leaves | 1, 10, 25, 50, 75, 100, 125, and 150 |
| Extract significantly decreased the cell viability with IC50 24.03 | [ | |||
|
| ||||||||
| 4 | Antidiabetic activity | Methanolic extract | Bark | 200, 350, and 620 mg/kg/day, p.o. | Metformin 45 mg/kg | Streptozotocin-nicotinamide-induced type II diabetes mellitus using female Sprague-Dawley rats | Extract significantly decreased the level of serum GLU, creatinine, urea, triglycerides, cholesterol, low-density lipoprotein-cholesterol, and very low-density lipoprotein-cholesterol and increased high-density lipoprotein levels | [ |
| Geraldone, isookanin, and luteolin | Bark | Acarbose 10 mg/ml |
| All three compounds significantly inhibit the | [ | |||
| Methanol/dichloromethane extract | Stem bark | 100–400 mg/kg | Glibenclamide 1 mg/kg |
| Significant reduction of blood glucose, BUN, SCr, GSP, TC, TG, LDL-c, and VLDL-c and increasing plasma insulin level, hepatic enzymes, SOD, CAT, GSH, and HDL-c | [ | ||
|
| ||||||||
| 5 | Antidiarrheal activity | Aqueous methanol extract | Seed | 2.5–5 mg/kg i.p. | Loperamide 1 mg/kg i.p. |
| Extract significantly inhibited the cathartic effect of castor oil in a dose-dependent manner | [ |
| 6 | Anti-inflammatory activity | Essential oil | Leaves | 100–400 mg/kg p.o. | Ibuprofen 100 mg/kg |
| Extract significantly and dose-dependently inhibited edema | [ |
| Aqueous and ethanolic extract | Leaves | 50–200 mg/kg, p.o. | Diclofenac 20 mg/kg and indomethacin 10 mg/kg |
| Dose-dependent and significant inhibition of inflammation | [ | ||
| Petroleum ether, chloroform, and ethanol extract | Bark | 100, 200, and 400 mg/kg p.o. | Indomethacin 10 mg/kg |
| Dose-dependent and significant inhibition of inflammation | [ | ||
| n-Hexane, dichloromethane, ethyl acetate, and n-butanol fraction | Flower | 0.25 and 1 g/kg, i.p. | Diclofenac sodium 20 mg/kg |
| All fractions showed significant inhibition | [ | ||
| Petroleum ether: ethyl acetate: methanol extract (1 : 1:1) | Bark | 200 and 400 mg/kg p.o. | Phenylbutazone 100 mg/kg |
| Dose-dependent and significant inhibition of inflammation | [ | ||
|
| ||||||||
| 7 | Antimicrobial activity | Zinc oxide nanoparticles | Stem bark | 0.01 M, 0.05 M, and 0.1 M | Ciprofloxacin 10 |
| Extract showed strong activity with inhibition zone ranging from 1 to 10.57 mm | [ |
| Ethanolic extract | Root | 100–200 mg/ml | Ciprofloxacin |
| Extract showed activity against all tested bacteria with a zone of inhibition ranging from 9.05 to 15.77 mm and MIC 0.20–1.56 mg/ml | [ | ||
| Petroleum ether, ethyl acetate, and methanol extracts | Stem bark | 300 | Ciprofloxacin 10 |
| Pet. ether and ethyl acetate extract showed activity against selective microbes with ZOI ranging from 6 to 14 mm. Methanol extract is only active against | [ | ||
| Petroleum ether, ethyl acetate, and methanol extract | Leaves | 50, 100, 200, and 500 | Tetracycline, streptomycin, erythromycin, lincomycin, rifampicin, norfloxacin, and gentamycin |
| Among extracts, methanolic extract showed strong activity with a zone of inhibition ranging from 11 to 23 mm at 500 | [ | ||
| Crude methanol extract | Leaves | 10 mg/ml | Ampicillin 10 mg/ml, streptomycin 10 mg/ml, and tetracycline 20 mg/ml |
| Extract showed potent antibacterial activity against | [ | ||
| 8 | Antinociceptive activity | Essential oil | Leaves | 100–400 mg/kg p.o. | Piroxicam 10 mg/kg p.o. |
| Extract inhibited nociceptive mediators at both neurogenic and inflammatory phases | [ |
| Aqueous and ethanolic extract | Leaves | 50–200 mg/kg, p.o. | Pentazocine 15 mg/kg |
| Both extracts showed a significant and dose-dependent increase in the mean basal reaction time in the hot plate test and latency of the flick tail response | [ | ||
| n-Hexane, dichloromethane, ethyl acetate, and n-butanol fraction | Flower | 0.25 and 1 g/kg, i.p. | Aspirin 200 mg/kg |
| Only dichloromethane fraction (1 g/kg) significantly increases in pain threshold | [ | ||
| Petroleum ether: ethyl acetate: methanol extract (1 : 1:1) | Bark | 200 and 400 mg/kg p.o. | Aminopyrine 50 mg/kg | Acetic acid induced writhing test using Swiss albino mice | Extract showed a significant and dose-dependent reduction in the number of writhes | [ | ||
| Morphine 2 mg/kg | Radiant heat tail-flick method using Swiss albino mice | Extract showed significant elongation of tail flicking time | ||||||
|
| ||||||||
| 9 | Antioxidant activity | Zinc oxide nanoparticles | Stem bark | 0.01, 0.05, and 0.1 M | Ascorbic acid | H2O2-free radical scavenging assay | IC50 48.7, 60.2, and 48.5 | [ |
| Geraldone, isookanin, and luteolin | Bark | Trolox | DPPH radical scavenging assay | All compounds showed activity with IC50 21.5, 31.8, and 29.26 | [ | |||
| Petroleum ether, ethyl acetate, and methanol extracts | Stem bark | 20–100 | Ascorbic acid | DPPH- and H2O2-free radical scavenging assay | Extracts showed DPPH- and H2O2-free radical scavenging activity with IC50 values of 66.63, 57.25, 60.21, 70.93, 64.69, and 68.99 | [ | ||
| Crude methanol extract | Leaves | 1, 10, 25, 50, 75, 100, 125, and 150 | Ascorbic acid | DPPH and ABTS radical scavenging assays | Extract exhibited DPPH and ABTS radical scavenging activity with IC50 34.22 and 108.7 | [ | ||
|
| ||||||||
| 10 | Antiparasitic activity | Ethanolic extract | Bark | 5–100 | Chloroquine 5 mg/kg |
| IC50 = 8.2 and 5.1 | [ |
| Ethanolic extract | Bark | 100, 250, 500, 750, and 1000 mg/kg/day | Chloroquine 5 mg/kg and pyrimethamine 1.25 mg/kg |
| Dose-dependent chemosuppression was observed with significant schizonticidal activity at 1000 mg/kg with ED > 100 mg/kg. Significant curative and repository activities were exhibited by 750 mg/kg concentration of extract on day 7 | |||
| Methanol extract | Pericarp | 20 mg/ml | Chloroquine, miltefosine, benznidazole, and suramin |
| Extract showed antiparasitic activity with IC50 8.7, 8.1, 37.9, and 50.8 | [ | ||
|
| ||||||||
| 11 | Anti-Parkinson's activity | Aqueous methanolic extract | Seed | 100–300 mg/kg | Sinemet-levodopa 100 mg + carbidopa 25 mg/kg per oral |
| Extract improved the motor functions and showed significant improvement in catalepsy, time latency, no. of exploration, ↑ SOD, CAT, and GSH | [ |
| Assessment of catalepsy, hang test, and narrow beam walk test | ||||||||
| Open field test | ||||||||
| 12 | Antipyretic activity | n-Hexane, dichloromethane, ethyl acetate, and n-butanol fraction | Flower | 0.25 and 1 g/kg, i.p. | Aspirin (200 mg/kg) |
| All fractions showed a decrease in temperature | [ |
| 13 | Antivenom activity | Methanolic extract | Seed | 1: 1–1: 100 w/w |
| Extract inhibited protease and hyaluronidase (IC50 36.32 and 91.95 | [ | |
| 14 | Estrogenic activity | n-Hexane, dichloromethane, ethyl acetate, and n-butanol fraction | Flower | 200 and 500 mg/kg i.p. | 17- | Uterine weight using female Albino mice | Ethyl acetate (200) and total alcohol fraction (500 mg/kg) significantly decrease and increase uterine weight by 25.2 and 109%, respectively | [ |
| 15 | Wound healing activity | Ethanolic extract | Root | 250, 500, and 750 mg/kg p.o. | Vitamin E 200 mg/kg |
| ↑ Wound breaking strength in incision model, complete wound contraction was observed on the 22nd day in excision model, ↑ wet weight of granulation tissue, total protein, SOD, GSH, hydroxyproline, hexosamine, hexuronic acid levels, ↓ lipid peroxidation, and nitric oxide | [ |